Nasus Pharma collaborates with Aptar to support development and commercialization of NS002: Tel Aviv Saturday, October 11, 2025, 12:00 Hrs [IST] Nasus Pharma Ltd, a clinical-stage ...

Instead of stabbing yourself, or someone else, in the thigh with a needle to deliver a dose of adrenaline to counter ...

Cancer remains a leading cause of global morbidity and mortality. Traditional therapies like chemotherapy and radiotherapy are often limited by their ...

Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage ...

AstraZeneca Plc said on Thursday its asthma treatment for a chronic inflammatory disease of the nasal passage linings, or sinuses, met main goals in a late-stage study.

PagePeek introduces an AI-powered assessment framework for rhinology, auditing imaging and anatomy, molecular mechanisms, ...

Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body ...

In the form of a 'nasal spray', tiny gold particles act as carriers, delivering a treatment directly to the brain: developed by scientists at the Università Rome campus/Fondazione Policlinico ...

Tiny gold particles that act as carriers for lithium can be delivered directly to the brain in the form of a nasal spray.

Application Receives FDA Authorization to Proceed RALEIGH, NORTH CAROLINA / ACCESS Newswire / October 8, 2025 / Belhaven ...

The latest announcement is out from Nasus Pharma Ltd. ( (NSRX) ).

"This collaboration represents a significant milestone for Nasus Pharma and for our NS002 program," said Dan Teleman, Chief Executive Officer of Nasus Pharma. "Through this collaboration, Nasus Pharma ...